Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.77 |
| ▸ | LMNA | P02545 | 5/20 | 0.77 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.75 |
| ▸ | MAPT | P10636 | 2/20 | 0.75 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.75 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.75 |
| ▸ | ESR1 | P03372 | 5/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.71 |
| ▸ | PGR | P06401 | 2/20 | 0.71 |
| ▸ | AR | P10275 | 2/20 | 0.71 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.71 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.71 |
| ▸ | ATM | Q13315 | 2/20 | 0.71 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.71 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.71 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.71 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.71 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.71 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.71 |
| ▸ | STS | P08842 | 2/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18487958 | 1.00 | HSD17B10 (0.77) | HSD17B10LMNAALDH1A1MAPTCYP2C9 | |
| SCHEMBL18541855 | 1.00 | HSD17B10 (0.77) | HSD17B10LMNAALDH1A1MAPTCYP2C9 | |
| SCHEMBL10615356 | 0.98 | HSD17B10 (0.74) | HSD17B10LMNAALDH1A1MAPTCYP2C9 | |
| SCHEMBL7537644 | 0.97 | HSD17B10 (0.72) | HSD17B10LMNAALDH1A1MAPTCYP2C9 | |
| SCHEMBL18687578 | 0.97 | HSD17B10 (0.75) | HSD17B10LMNAALDH1A1MAPTCYP2C9 | |
| SCHEMBL28503910 | 0.97 | HSD17B10 (0.75) | HSD17B10LMNAALDH1A1MAPTCYP2C9 | |
| SCHEMBL19732547 | 0.96 | HSD17B10 (0.71) | HSD17B10LMNAALDH1A1MAPTCYP2C9 | |
| SCHEMBL21338341 | 0.96 | HSD17B10 (0.71) | HSD17B10LMNAALDH1A1MAPTCYP2C9 | |
| SCHEMBL21338329 | 0.93 | HSD17B10 (0.70) | HSD17B10LMNAALDH1A1MAPTCYP2C9 | |
| SCHEMBL17972779 | 0.93 | HSD17B10 (0.70) | HSD17B10LMNAALDH1A1MAPTCYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9687556-B2 | Compounds and methods for trans-membrane delivery of molecules | APOSENSE LTD. (IL) | 2017-06-27 | — | — | US | disclosed |
| US-20170100486-A1 | COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES | APOSENSE LTD. (IL) | 2017-04-13 | — | — | US | disclosed |
| US-20170080095-A1 | COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES | APOSENSE LTD. (IL) | 2017-03-23 | — | — | US | disclosed |
| US-20170037401-A1 | COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES | APOSENSE LTD. (IL) | 2017-02-09 | — | — | US | disclosed |
| WO-2017017669-A1 | PRO-DRUGS AND RELATED METHODS | APOSENSE LTD. (IL) | 2017-02-02 | — | — | WO | disclosed |
| US-20160129125-A1 | COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES | APOSENSE LTD. (IL) | 2016-05-12 | — | — | US | disclosed |
| US-20160120996-A1 | COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES | APOSENSE LTD. (IL) | 2016-05-05 | — | — | US | disclosed |
| US-20160106855-A1 | COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES | APOSENSE LTD. (IL) | 2016-04-21 | — | — | US | disclosed |
| US-20020035100-A1 | Alkyl ether modified polycyclic compounds having a terminal phenol and uses for protection of cells | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2002-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170080095-A1 | COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES | ABCB4, LNPK, MBOAT1 | HSD17B10 3759/4885LMNA 232/4885ALDH1A1 3993/4885 |
| US-20160129125-A1 | COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES | ABCB4, LNPK, NPC1L1 | HSD17B10 3671/4885LMNA 243/4885ALDH1A1 3911/4885 |
| US-20170100486-A1 | COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES | ABCB4, LNPK, MBOAT1 | HSD17B10 3759/4885LMNA 232/4885ALDH1A1 3993/4885 |
| US-20160106855-A1 | COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES | ABCB4, LNPK, NPC1L1 | HSD17B10 3671/4885LMNA 243/4885ALDH1A1 3911/4885 |
| US-20160120996-A1 | COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES | ABCB4, LNPK, MBOAT1 | HSD17B10 3759/4885LMNA 232/4885ALDH1A1 3993/4885 |
| US-20170037401-A1 | COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES | ABCB4, LNPK, MBOAT1 | HSD17B10 3759/4885LMNA 232/4885ALDH1A1 3993/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.